[
  {
    "data": {
      "text": "Zhyttya-Buttya, Zvychai i Obychai girskogo Narodu. Zorya.Kyrchiv, R. (1978). Etnografichne Doslidzhennya Boykivschyny. Kyiv: Naukovadumka.Lepkij, D. (1884). Pro narodni Zabobony. Zorya. 5, 105-124.Lisowski, W. (2007). Doktor Jan Stanko. Skalpel 2, 28-31.Magowska, A. (2004).History of Polish pharmacopoeias. Poznan: Nakladem autora.Mirzoyeva, T. (2013). Perspektyvy rozvytku likarskogo roslynnyctva. NVNUB 181,176-181.Nimchuk, V. (1976). Mova ukrajinskogo travnyka XVI stolittya. Movoznavstvo 5,43-55.Nosal, M., and Nosal, I. (1962). Likarski Roslyny i Sposoby yikh Zastosuvannia vNarodi. Kyiv: Zdorovya.Novoselski, A., and Pushkarev, L. (1977).Drevneruskij Lechebnik, Redkije Istochnikipo Istorii Rossii. Moscow: AN USSR.Nykytyuk, Y. (2015). Rozvytok zovnishnoi torgivli likaskoyu roslynnoyusyrovynoyu. NVUNU 4, 62-66.Otchet (1915). Otchet ob Sostojanii Narodnogo Zdravija i Organizacii VrachebnojPomoschi v Rosii. Sankt-Petersburg: Trud.Onipko, T. (2010). Vyrobnychi Galuzi Spozhyvchoi Kooperatsiji Ukrajinyv Konteksti Novoi Ekonomichnoi Polityky (1921-1928). Poltava: PoltavaEconomic University.Ostling, M. (2014). Witches' Herbs on Trial. Folklore 125, 179-201.Papee, F. (1891). Skole i Tucholszczyzna: Monografia Historyczna. Lwow:Gubrynowicz i Schmidt.Peredrijenko, V. (1984). Likarski ta Hospodarski Porandyky XVIII st. Kyiv:Naukova dumka.Petrova, A. (2005). Current State of Bulgarian Biodiversity-Problems andPerspectives. Sofia: Bulgarian Bioplatform.Prioreschi, P. (2000). Alternative medicine in ancient and medievalhistory. Med. Hypotheses 55, 319-325. doi: 10.1054/mehy.2000.1061Prioreschi, P. (2003). A History of medicine: V. Medieval Medicine. Omaha:Horatius Press.Rostafinski, J. (1888). Pamietnik. Polska Akademia Umiejetnos'ci Wydzial.Rostanski, K. (1997). Szymon Syreniusz i jego dzielo. Wiadomosci Bot.41, 7-12.Schneider, J. (1912). Z zycia gorali nadlomnickich. Lud Lviv 18, 176-193.Singer, C. (1927). The Herbal in Antiquity and its Transmission to later Ages. J.Hell. Stud. 47, 1-52. doi: 10.2307/625251Stavrovsky, E. (1967). Slovensko-Polsko-Ukrajinske Pohranicie do 18 Storocia.Bratislava: Slovenske pedagogicke nakladatelstvo.Syrku, P. (1883). Otryvok malorusskogo prostonarodnogo lechebnogo travnika idva zagovora. Filol. Zap. 22, 1-12.Szuchewycz, W. (1908). Huculszczyzna. Lviv: NTS.Talko-Hryncewicz, J. (1893). Zarys lecznictwa ludowego na Rusi Poludniowej.Krakow: Academia Umiejetnosci.Frontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 295231Kozlowska et al. Botanical Provenance of Carpathian Herbal MedicinesTheodorescu, R. (1989). The beginnings of higher education in Eastern Europe:paduan internationalism. High. Educ. Eur. 14, 54-58. doi: 10.1080/0379772890140108Tovstuha, Y. (1990). Fitoterapiya. Kyiv: Zdorovya.Tylkowa, D. (1989). Medycyna ludowa w Kulturze wsi Karpat Polskich: Tradycja iWspolczesnos'c'. Wroclaw: Zaklad Narodowy Ossolinskich.Wagner, C. S., De Gezelle, J., Robertson, M., Robertson, K., Wilson, M., andKomarnytsky, S. (2017). Antibacterial activity of medicinal plants fromThe Physicians of Myddvai, a 14th century Welsh medical manuscript.J. Ethnopharmacol. 203, 171-181. doi: 10.1016/j.jep.2017.03.039Zmejev, L. (1895). Russkie vrachebniki. Saint Peterburg: Pammiatniki DrevniejPismennosti.Conflict of Interest Statement: The authors declare that the research wasconducted in the absence of any commercial or financial relationships that couldbe construed as a potential conflict of interest.Copyright (c) 2018 Kozlowska, Wagner, Moore, Matkowski and Komarnytsky.This is an open-access article distributed under the terms of the CreativeCommons Attribution License (CC BY). The use, distribution or reproductionin other forums is permitted, provided the original author(s) and thecopyright owner are credited and that the original publication in thisjournal is cited, in accordance with accepted academic practice. No use,distribution or reproduction is permitted which does not comply with theseterms.Frontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 295232fphar-09-00304 March 28, 2018 Time: 17:7 # 1ORIGINAL RESEARCHpublished: 03 April 2018doi: 10.3389/fphar.2018.00304Edited by:Judit Hohmann,University of Szeged, HungaryReviewed by:Didem Sohretoglu,Hacettepe University, TurkeyGabor Vasas,University of Debrecen, Hungary*Correspondence:Ali Ozmenaozmen@adu.edu.trLiselotte Krennliselotte.krenn@univie.ac.atSpecialty section:This article was submitted toEthnopharmacology,a section of the journalFrontiers in PharmacologyReceived: 04 October 2017Accepted: 15 March 2018Published: 03 April 2018Citation:Lewenhofer V, Schweighofer L,Ledermuller T, Eichsteininger J,Kahlig H, Zehl M, Nguyen CH,Krupitza G, Ozmen A and Krenn L(2018) Chemical Compositionof Scrophularia lucida and the Effectson Tumor Invasiveness in Vitro.Front. Pharmacol. 9:304.doi: 10.3389/fphar.2018.00304Chemical Composition ofScrophularia lucida and the Effectson Tumor Invasiveness in VitroVerena Lewenhofer1, Lisa Schweighofer1, Tobias Ledermuller1, Julia Eichsteininger1,2,Hanspeter Kahlig3, Martin Zehl1,4, Chi H. Nguyen2,5,6, Georg Krupitza2, Ali Ozmen7* andLiselotte Krenn1*1 Department of Pharmacognosy, Faculty of Life Sciences, University of Vienna, Vienna, Austria, 2 Clinical Institute ofPathology, Medical University of Vienna, Vienna, Austria, 3 Department of Organic Chemistry, Faculty of Chemistry, Universityof Vienna, Vienna, Austria, 4 Department of Analytical Chemistry, Faculty of Chemistry, University of Vienna, Vienna, Austria,5 Department of Clinical Pharmacy and Diagnostics, Faculty of Life Sciences, University of Vienna, Vienna, Austria,6 Department of Medicine I and Comprehensive Cancer Center, Medical University of Vienna, Vienna, Austria,7 Department of Biology, Faculty of Science and Art, Adnan Menderes University, Aydin, TurkeyA detannified methanolic extract of Scrophularia lucida L. attenuated the formationof cancer cell-induced circular chemorepellent induced defects (CCIDs) in the lymphendothelial cell barrier, which resemble entry ports for the intravasating tumor into thevasculature as a prerequisite for lymph node metastasis. Therefore, the composition ofthis extract was studied in an activity-guided approach. Since no data on the secondarymetabolites of this plant were available, first phytochemical data were collected in thecourse of the fractionation of the extract. The study resulted in the identification of 14substances, among them very rare iridoids, such as scrovalentinoside or koelzioside,and several flavonoids (e.g., nepitrin and homoplantaginin). One of the latter group,2''-O-acetyl-homoplantaginin, is a new natural compound. In the most active fraction,the flavonoid hispidulin was identified as major component and the assay of thepure compound confirmed a contribution of hispidulin to the CCID-inhibitory effectsof S. lucida. The activity of the two major iridoids in this assay was less compared tohispidulin.Keywords: Scrophularia lucida L., iridoids, phenolic compounds, 2''-O-acetyl-homoplantaginin, hispidulin,intravasation, circular chemorepellent-induced defects (CCID) assayINTRODUCTIONSpecies of the genus Scrophularia have been applied for centuries in traditional medicine.The most important one among those, Scrophularia ningpoensis Hemsl., is widely used intraditional Chinese medicine for a broad spectrum of inflammatory diseases (De SantosGalindez et al., 2002; Tong et al., 2006; Li et al., 2009) and listed in the ChinesePharmacopeia against febrile diseases with excessive thirst or eruptions, constipation, coughdue to exhaustion, conjunctivits, skin disorders, and others (Stoger, 2017). The use in theFrontiers in Pharmacology | www.frontiersin.org April 2018 | Volume 9 | Article 304233fphar-09-00304 March 28, 2018 Time: 17:7 # 2Lewenhofer et al. Scrophularia lucida in CCID Assaytreatment of inflammatory disorders, wound healing, skinailments, and health disturbances has been reported fornumerous species such as Scrophularia auriculata L. orScrophularia canina L. from the Mediterranean area (Giner et al.,2000; Guarrera and Lucia, 2007; Passalacqua et al., 2007) as well asfor Scrophularia variegata M. Bieb. and Scrophularia striata Boiss.in traditional Iranian medicine (Azadmehr et al., 2013, 2015).A traditional use as an antipyretic and anti-inflammatory agentwas described for Scrophularia oldhamii Oliv. and as a diuretic forScrophularia grossheimii Schischkin (De Santos Galindez et al.,2002). In Turkish traditional medicine, the species Scrophularianodosa L. is well-known as a diuretic, to treat hemorrhoids, andalso for wound healing, eruptive skin diseases, eczema, psoriasis,and pruritus (Baytop, 1999; Stevenson et al., 2002; Crisan et al.,2009). A use in these indications is also conveyed for the Turkishspecies Scrophularia depauperata Boiss., Scrophularia cryptophilaBoiss. et. Heldr. Boiss., and Scrophularia floribunda Boiss. et. Bal. (Ozbilgin et al., 2014).Recently, the activity of various extracts from severalScrophularia species has been studied in different cancer models:weak cytotoxic activity of an ethanolic extract from S. striatavia induction of apoptosis and G2/M phase arrest was shownin Jurkat human leukemia cells (Azadmehr et al., 2013). InWEHI 164 fibrosarcoma cells, a methanolic extract of this plantexhibited a significant and dose-dependent reduction of theactivity of matrix metalloproteinases (Hajiaghaee et al., 2007),which play a role in tissue remodeling and tumor invasion.An apolar fraction from a methanolic extract of Scrophulariaorientalis L. significantly reduced the viability of neuroblastomacells due to a loss of mitochondrial membrane integrity (Langeet al., 2016). In MCF-7 breast cancer cells, weak cytotoxicity of anethanolic extract from S. variegata was reported (Azadmehr et al.,2015). A dichloromethane extract from Scrophularia oxysepalacaused significant cytotoxic and apoptotic effects in MCF-7 cellsby influencing the expression of p53, caspase 3, and c-myc, andthe cleavage of PARP (Valiyari et al., 2013). The anti-tumoractivity of S. oxysepala in breast cancer was confirmed in vivo inan allograft model in mice inoculated with mammary carcinoma4T1 cells. Animals treated with 50 or 100 mg/kg of an ethanolicextract developed significantly smaller tumors in size and weight(Baradaran et al., 2017). In a study of five Scrophularia species,S. floribunda and Scrophularia lucida L. displayed the highestcytotoxic activity against HL-60 promyeloic leukemia cells. Theseextracts were also tested in a three-dimensional co-culture cellmodel consisting of MCF-7 breast cancer spheroids placed on topof telomerase-immortalized human lymph endothelial cell (LEC)monolayers. There, tumor spheroids cause the formation of largecell-free areas in the lymph endothelial barrier, so-called \"circularchemorepellent induced defects\" (CCIDs), through which tumorcells penetrate the vasculature. This assay mimics intravasationwhich is an early step within the metastatic cascade resemblingthe pathological situation in rodents and humans (Madleneret al., 2010; Vonach et al., 2011; Viola et al., 2013). A detannifiedmethanolic extract of S. lucida L. was the most active one insuppressing CCID formation (Giessrigl et al., 2012).The lack of any information about the chemical compositionof S. lucida prompted us to perform an activity-guided search forthe active principle of this species contributing to the inhibitoryeffect in the CCID assay.EXPERIMENTALGeneral Experimental ProceduresHispidulin was obtained from Sigma-Aldrich. All otherflavonoids for dereplication were on stock at the Department ofPharmacognosy, University of Vienna.For TLC, silica gel plates or HPTLC plates RP-8 (Merck,Germany) and the mobile phases (1) CHCl3-CH3COOHconc.-MeOH-H2O (60:32:12:18), (2) EtOAc-HCOOHconc.-CH3COOHconc.-H2O (100:11:11:20), (3) EtOAc-MeOH-HCOOHconc.-H2O (75:15:4:4), or (4) MeOH-H2O (90:10)were used.A Shimadzu LC-20AD pump, an SPD M20A diode arraydetector, a CTO-20AC column oven, and a SIL 20AC HTauto-sampler (Kyoto, Japan) served for analytical HPLC on aLuna 5 u C-18 (250 mm x 4.6 mm) column (Phenomenex,United States) at 25*C and a flow rate of 1 mL/min. Mobilephase 1 consisted of (A) aqueous formic acid (pH 3) and (B)acetonitrile-aqueous formic acid (pH 3; 80+2) and the gradientprogram 1 was 5% B (0 min), 20% B (15 min), 20% B (25 min),50% B (65 min), and 95% B (80 min). Mobile phase 2 was (A)aqueous formic acid (pH 3) and (B) acetonitrile and the gradient2 increased from 5% B (0 min) to 95% B (60 min). UV datawere recorded from 190 to 400 nm. All solvents of analytical orHPLC-grade (acetonitrile, Chromanorm; methanol, LiChrosolv)were obtained from VWR International (West Chester, PA,United States) and CH3COOHconc."
    },
    "predictions": [
      {
        "result": [
          {
            "id": "entity_0",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 4775,
              "end": 4794,
              "text": "Scrophularia lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_1",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 4930,
              "end": 4936,
              "text": "lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_2",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 5891,
              "end": 5910,
              "text": "Scrophularia lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_3",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 5941,
              "end": 5947,
              "text": "cancer",
              "labels": [
                "Medical Condition"
              ]
            }
          },
          {
            "id": "entity_4",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 6985,
              "end": 7004,
              "text": "Scrophularia lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_5",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 7836,
              "end": 7855,
              "text": "Scrophularia lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_6",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 9080,
              "end": 9086,
              "text": "cancer",
              "labels": [
                "Medical Condition"
              ]
            }
          },
          {
            "id": "entity_7",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 9099,
              "end": 9108,
              "text": "cytotoxic",
              "labels": [
                "Medicinal Effect"
              ]
            }
          },
          {
            "id": "entity_8",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 9736,
              "end": 9742,
              "text": "cancer",
              "labels": [
                "Medical Condition"
              ]
            }
          },
          {
            "id": "entity_9",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 9918,
              "end": 9927,
              "text": "cytotoxic",
              "labels": [
                "Medicinal Effect"
              ]
            }
          },
          {
            "id": "entity_10",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 9932,
              "end": 9941,
              "text": "apoptotic",
              "labels": [
                "Medicinal Effect"
              ]
            }
          },
          {
            "id": "entity_11",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 10077,
              "end": 10082,
              "text": "anti-",
              "labels": [
                "Medicinal Effect"
              ]
            }
          },
          {
            "id": "entity_12",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 10122,
              "end": 10128,
              "text": "cancer",
              "labels": [
                "Medical Condition"
              ]
            }
          },
          {
            "id": "entity_13",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 10425,
              "end": 10444,
              "text": "Scrophularia lucida",
              "labels": [
                "Scientific Plant Name"
              ]
            }
          },
          {
            "id": "entity_14",
            "from_name": "label",
            "to_name": "text",
            "type": "labels",
            "value": {
              "start": 10631,
              "end": 10637,
              "text": "cancer",
              "labels": [
                "Medical Condition"
              ]
            }
          },
          {
            "from_id": "entity_0",
            "to_id": "entity_3",
            "type": "relation",
            "labels": [
              "treats_medical_condition"
            ]
          },
          {
            "from_id": "entity_13",
            "to_id": "entity_6",
            "type": "relation",
            "labels": [
              "has_medicinal_effect"
            ]
          }
        ]
      }
    ]
  }
]